4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000128
Chief Medical Officer sold 10,369 shares at $43.01 ($445,982)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-10-15 | Sale 10b5-1 | −10,369 | $43.01 | $445,982 | 71,155 | D |
| Open-market sales · 10,369 sh · avg $43.01 · $445,982 | |||||||
Loading xslF345X05/wk-form4_1760569464.xml…